The Effect of 12‐O‐Tetradecanoyl‐phorbol 13‐Acetate on the Ribormclease Activity of Circulating Human Lymphocytes

David KYNER, Judith K. CHRISTMAN, George ACS

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

12‐O‐Tetradecanoyl‐phorbol 13‐acetate is a very effective tumor promoter and inflammatory agent and can act as a mitogen for a subset of T lymphocytes. We report here that even short exposure of lymphocytes to 12‐O‐tetradecanoyl‐phorbol 13‐acetate changes the balance between the levels of neutral ribonuclease and ribonuclease inhibitor. The most dramatic change occurs in a B‐lymphocyte‐enriched population. We find that most, if not all, of the neutral ribonuclease activity in circulating lymphocytes is associated with this population and that this activity is lost with exposure to 12‐O‐tetradecanoyl‐phorbol 13‐acetate. Both 12‐O‐tetradecanoyl‐phorbol 13‐acetate and phytohaemagglutinin increase the level of ribonuclease inhibitor in T cells. However, phytohaemagglutinin has no effect on the ribonuclease or inhibitor level of the B‐cell‐enriched population.

Original languageEnglish
Pages (from-to)395-399
Number of pages5
JournalEuropean Journal of Biochemistry
Volume99
Issue number2
DOIs
StatePublished - Sep 1979
Externally publishedYes

Fingerprint

Dive into the research topics of 'The Effect of 12‐O‐Tetradecanoyl‐phorbol 13‐Acetate on the Ribormclease Activity of Circulating Human Lymphocytes'. Together they form a unique fingerprint.

Cite this